Carvedilol Tablets Recalled for Carcinogenic N-Nitroso Impurity Manufacturing Defect
Glenmark Pharmaceuticals is recalling carvedilol tablets nationwide due to N-nitroso carvedilol I (NNCI-I), a carcinogenic impurity found in certain lots. The impurity exceeds FDA safety limits.
- Product
- CARVEDILOL — CARVEDILOL (CARVEDILOL)
- Category
- Drug
- Distribution
- Distributed nationwide